Peptidylarginine Deiminase Autoimmunity and the Development of Anti–Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten–Carrier Model. Issue 6 (26th April 2020)

• Record Type: Journal Article
• Authors: Auger, Isabelle; Balandraud, Nathalie; Massy, Emmanuel; Hemon, Marie F.; Peen, Elisa; Arnoux, Fanny; Mariot, Charlotte; Martin, Marielle; Lafforgue, Pierre; Busnel, Jean‐Marc; Roudier, Jean
• Is Part Of: Arthritis & rheumatology. Volume 72:Issue 6(2020)
• Page Start: 903
• Page End: 911
• Publication Date: 2020-04-26
• Subjects: Arthritis -- Periodicals; Rheumatism -- Periodicals; 616.72
• DOI: 10.1002/art.41189
• Languages: English
• ISSNs: 2326-5191

Abstract

Abstract : Objective: The presence of autoantibodies to citrullinated proteins (ACPAs) often precedes the development of rheumatoid arthritis (RA). Citrullines are arginine residues that have been modified by peptidylarginine deiminases (PADs). PAD4 is the target of autoantibodies in RA. ACPAs could arise because PAD4 is recognized by T cells, which facilitate the production of autoantibodies to proteins bound by PAD4. We previously found evidence for this hapten–carrier model in mice. This study was undertaken to investigate whether there is evidence for this model in humans. Methods: We analyzed antibody response to PAD4 and T cell proliferation in response to PAD4 in 41 RA patients and 36 controls. We tested binding of 65 PAD4 peptides to 5 HLA–DR alleles (DRB1*04:01, *04:02, *04:04, *01:01, and *07:01) and selected 11 PAD4 peptides for proliferation studies using samples from 22 RA patients and 27 controls. Peripheral blood lymphocytes from an additional 10 RA patients and 7 healthy controls were analyzed by flow cytometry for CD3, CD4, CD154, and tumor necrosis factor expression after PAD4 stimulation. Results: Only patients with RA had both antibodies and T cell responses to PAD4. T cell response to peptide 8, a PAD4 peptide, was associated with RA ( P = 0.02), anti‐PAD4 antibodies ( P = 0.057), and the shared epitope ( P = 0.05). Conclusion: ACPA immunity is associated with antibodies to PAD4 and T cell responses to PAD4 and PAD4 peptides. These findings are consistent with a hapten–carrier model in which PAD4 is the carrier and citrullinated proteins are the haptens.